Arteris Announces New Employment Inducement Grants

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

CAMPBELL, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that the company has granted an aggregate of 260,483 restricted stock units (RSUs) to four newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Thursday, January 12, 2023

Information

Tags:

SOC, Arteris, IP, RSU, AIP, Pharmaceutical industry

Geotags:

CAMPBELL, CA, US

⚠ partially generated by AI ↴

Organisation:

ARTERIS, ARTERIS, INC.

Summary

Key Points:

CAMPBELL, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that the company has granted an aggregate of 260,483 restricted stock units (RSUs) to four newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan.
The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
The effective RSU grant date is January 10, 2023, and it was approved by the company’s board of directors.

CAMPBELL, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that the company has granted an aggregate of 260,483 restricted stock units (RSUs) to four newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).

The effective RSU grant date is January 10, 2023, and it was approved by the company’s board of directors.

About Arteris

Arteris is a leading provider of system IP for the acceleration of system-on-chip (SoC) development across today’s electronic systems. Arteris network-on-chip (NoC) interconnect IP and IP deployment technology enable higher product performance with lower power consumption and faster time to market, delivering better SoC economics so its customers can focus on dreaming up what comes next. Learn more at arteris.com.

© 2004-2023 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
[email protected]

Investor Relations Contact:
Sapphire Investor Relations, LLC
Erica Mannion or Mike Funari
+1 617 542 6180
[email protected]